Fundz

Gedea Biotech Appoints Julie Waras Brogren as Chief Executive Officer

PRIVATEJan 27, 2026

Position

Chief Executive Officer

Company

Gedea Biotech

Julie Waras Brogren
BiotechnologyHealth Care

Description

Gedea Biotech announces that Julie Waras Brogren has been appointed as the new CEO, succeeding Annette Säfholm. Ms. Waras Brogren will assume her role in early April 2026.

Quick answer

Gedea Biotech Appoints Julie Waras Brogren as Chief Executive Officer (January 27, 2026).

Who is the new Chief Executive Officer at Gedea Biotech?
Gedea Biotech named Julie Waras Brogren Chief Executive Officer, announced January 27, 2026.
What did Gedea Biotech announce on January 27, 2026?
Gedea Biotech announces that Julie Waras Brogren has been appointed as the new CEO, succeeding Annette Säfholm. Ms. Waras Brogren will assume her role in early April 2026.
What does Gedea Biotech do?
Gedea Biotech is a Swedish women’s health specialist focused on innovative solutions.
Which similar companies made leadership changes around the same time?
Cardiff Oncology (January 27, 2026), AdhereTech (January 27, 2026), The V Foundation for Cancer Research (January 27, 2026) and Lexeo Therapeutics (January 27, 2026) also announced leadership changes within 45 days of Gedea Biotech.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Gedea Biotech, and when

A new leader at Gedea Biotech brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Gedea Biotech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gedea Biotech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gedea Biotech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gedea Biotech

About

Gedea Biotech is a Swedish women’s health specialist focused on innovative solutions. The company has evolved from early scientific validation into a commercial-ready biotech. Gedea is dedicated to improving health outcomes for women through advanced technology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gedea Biotech changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Gedea Biotech's next move

Learn about Strategic plan

Gedea Biotech changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.